4D Molecular Therapeutics...
4.95
0.07 (1.43%)
At close: Jan 15, 2025, 12:28 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -100.84M -107.49M -71.32M -56.69M -49.31M -9.55M -11.22M
Depreciation & Amortization 5.75M 3.88M 3.02M 1.44M 1.00M 697.00K 626.00K
Stock-Based Compensation 19.66M 17.12M 13.80M 4.98M 3.54M 1.38M 256.00K
Other Working Capital -266.00K 255.00K -14.72M 345.00K -3.35M -8.59M 19.03M
Other Non-Cash Items -999.00K 1.14M 898.00K 48.00K 5.14M 2.00K 39.00K
Deferred Income Tax n/a n/a n/a 20.00K 2.65M n/a n/a
Change in Working Capital 630.00K -1.34M -15.53M -711.00K 259.00K -8.78M 18.54M
Operating Cash Flow -75.79M -86.69M -69.13M -50.91M -36.71M -16.25M 8.24M
Capital Expenditures -2.77M -11.54M -9.11M -1.00M -3.20M -414.00K -573.00K
Acquisitions n/a 11.54M 9.11M n/a n/a n/a 24.00K
Purchase of Investments -54.80M -153.31M -168.57M n/a n/a n/a n/a
Sales Maturities Of Investments 173.29M 147.80M 5.00M n/a n/a n/a 8.22M
Other Investing Acitivies n/a -11.54M -9.11M -1.00M n/a n/a 24.00K
Investing Cash Flow 115.72M -17.05M -172.68M -1.00M -3.20M -414.00K 7.67M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a -2.27M n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 8.49M 3.08M 3.79M 73.33M -10.00K 169.05M n/a
Financial Cash Flow 156.83M 3.08M 118.09M 278.98M -2.19M 84.58M 16.00K
Net Cash Flow 196.76M -100.65M -123.72M 227.07M -42.11M 67.91M 15.93M
Free Cash Flow -78.56M -98.22M -78.24M -51.91M -39.91M -16.67M 7.66M

Create Price Alert on FDMT

Your price alert will notify you when the stock price is above 4.95.

Add to Watchlist